Skip to main content
Download PDF

Changes in biomarkers of redox status in serum and saliva of dogs with hypothyroidism

BMC Veterinary Research volume 19, Article number: 33 (2023) Cite this article

Abstract

Background

Hypothyroidism is the most common endocrine disorder diagnosed in dogs, leading to deleterious effects on a dog’s life quality. This study aims to evaluate changes in the redox status in canine hypothyroidism. For this purpose, a comprehensive panel of antioxidants and oxidants biomarkers were measured in serum and saliva of 23 dogs with hypothyroidism, 21 dogs with non-thyroidal illness, and 16 healthy dogs. Among the antioxidants, cupric reducing antioxidant capacity (CUPRAC), ferric reducing ability of plasma (FRAP), Trolox equivalent antioxidant capacity (TEAC), thiol, paraoxonase type 1 (PON-1) and glutathione peroxidase (GPx) were determined in serum and CUPRAC, ferric reducing ability of saliva (FRAS) and TEAC in saliva. The oxidant biomarkers included were total oxidant status (TOS), peroxide-activity (POX-Act), reactive oxygen-derived compounds (d-ROMs), advanced oxidation protein products (AOPP), and thiobarbituric acid reactive substances (TBARS) in serum and AOPP and TBARS in saliva.

Results

Results showed a significantly higher TEAC, PON-1, GPx, TOS, POX-Act, and d-ROMs, and a significantly lower AOPP in serum of dogs with hypothyroidism. Meanwhile, significantly lower FRAS and AOPP were observed in saliva of dogs with hypothyroidism. Once salivary concentrations were corrected based on their total protein concentrations, the only analyte showing significant changes was TBARS which was significantly higher in dogs with hypothyroidism.

Conclusions

Our results show that dogs with hypothyroidism present alterations in the redox status in both serum and saliva. This study should be considered a preliminary study and further research addressing these changes should be made using larger populations.

Peer Review reports

Background

Hypothyroidism is described as a deficiency in the synthesis of thyroid hormones, namely, tetraiodothyronine (thyroxin, T4) and triiodothyronine (T3), due to an impairment of the thyroid gland, commonly associated in dogs with idiopathic follicular atrophy or destruction of the gland as a consequence of lymphocytic thyroiditis [1,2,3].

Thyroid hormones have an important association with oxidative status [4]. In physiological conditions, thyroid hormones have positive effects on metabolism, as they influence both catabolic and anabolic reactions. However, these reactions can lead to oxygen consumption, which is a key factor in the development and synthesis of reactive oxygen species (ROS). On the other hand, thyroid hormones also play an important role in the antioxidant defense system, as they act as part of this system being enzymatic and non-enzymatic free radical scavengers [3,4,5,6,7,8,9,10].

Markers of oxidative stress associated with hypothyroidism have been studied in humans, showing a decrease in antioxidants and an increase in lipid peroxidation [4]. Namely, a decrease in superoxide dismutase activity (SOD), catalase activity, and an overall increase in thiobarbituric acid reactive substances (TBARS) were found in red blood cell lysates of humans with hypothyroidism [11,12,13], and these changes were attenuated after treatment with levothyroxine [12].

In humans, serum has been traditionally used to evaluate changes in the oxidative status of patients with different thyroidal diseases [14,15,16,17]. However, saliva is an easy-to-obtain, stress-free sample that has been used for the study of different biomarkers in other diseases and species [18,19,20,21,22]. To the author’s knowledge, the oxidative status has not been evaluated in serum and saliva of dogs with hypothyroidism previously.

We hypothesized that biomarkers of the redox status could change in serum and saliva of dogs with hypothyroidism. Thus, the objective of this study was to evaluate biomarkers of the redox status in serum and saliva from dogs with hypothyroidism and compare them with dogs with non-thyroidal illnesses and healthy controls. A comprehensive panel of redox biomarkers was measured, including antioxidants as, the cupric ion reducing antioxidant capacity (CUPRAC), ferric reducing ability of plasma (FRAP), Trolox equivalent antioxidant capacity (TEAC), thiol, paraoxonase type-1 (PON-1) and glutathione peroxidase activity (GPx), and oxidants as, the total oxidant status (TOS), peroxide-activity (POX-Act), reactive oxygen-derived compounds (d-ROMs), advanced oxidation protein products (AOPP) and TBARS in serum and CUPRAC, FRAS, TEAC, AOPP and TBARS in saliva.

Results

Patient characteristics

A complete description of the dogs included in the study is presented in Table 1. There were no statistically significant differences between groups related to age or sex.

Table 1 Detailed characteristics (breed, mean age, and body condition score (BCS) of the different groups included in the study
Full size table

Serum

Antioxidant status

Results for the serum antioxidant biomarkers are shown in Fig. 1. TEAC and PON-1 showed significantly higher values in dogs with hypothyroidism compared to dogs with non-thyroid diseases (P = 0.0486 and P = 0.0069, respectively) and healthy dogs (P = 0.0420 and P = 0.0074, respectively). GPx activity showed significantly higher values in dogs with hypothyroidism compared to healthy dogs (P = 0.0344). No significant differences (P > 0.05) were found between groups in CUPRAC, FRAP, and thiol.

Fig. 1
figure 1

Results of antioxidant biomarkers in serum. Cupric reducing antioxidant capacity (CUPRAC); ferric reducing ability of plasma (FRAP); Trolox equivalent antioxidant capacity (TEAC); thiol, paraoxonase type-1 (PON-1), and glutathione peroxidase (GPx) in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs and controls (CT). Asterisks indicate significant differences between groups. *P ≤ 0.05

Full size image

Oxidant status

Results for the oxidant biomarkers for serum are shown in Fig. 2. TOS concentrations were significantly higher in dogs with hypothyroidism compared to dogs with non-thyroid diseases P = 0.0327) and healthy dogs (P = 0.0004). In addition, concentrations of POX-Act and d-ROMs were significantly higher in dogs with hypothyroidism (P = 0.0003) and P = 0.0066, respectively) and dogs with non-thyroid diseases (P = 0.0070) and P = 0.0280, respectively) in comparison to healthy dogs.

Fig. 2
figure 2

Results of oxidant biomarkers in serum. Total oxidant status (TOS); peroxide-activity (POX-Act); reactive oxygen-derived compounds (d-ROMs); advanced oxidation protein products (AOPP), thiobarbituric acid reactive substances (TBARS) and AOPP: albumin ratio in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs and controls (CT). Asterisks indicate significant differences between groups. *P ≤ 0.05, **P  ≤ 0.01, ***P ≤ 0.001

Full size image

Concentrations of AOPP before albumin correction were significantly lower in dogs with hypothyroidism in comparison to dogs with non-thyroid diseases (P = 0.031) and healthy dogs (P = 0.0143). However, no significant differences were found (P > 0.05) between groups in AOPP and TBARS when results were corrected by albumin concentrations.

Saliva

Antioxidant status

Results for the salivary antioxidant biomarkers are shown in Fig. 3. FRAS concentrations before protein correction were significantly lower in dogs with hypothyroidism in comparison to dogs with non-thyroid diseases (P = 0.0026) and healthy dogs (P = 0.0158). No statistical differences (P > 0.05) were found for CUPRAC and TEAC between groups. When the results were corrected by salivary protein, CUPRAC, FRAS, and TEAC showed no significant differences (P > 0.05) (Fig. 4).

Fig. 3
figure 3

Results of the measurement of antioxidant biomarkers in saliva. Cupric reducing antioxidant capacity (CUPRAC); ferric reducing ability of saliva (FRAS), and Trolox equivalent antioxidant capacity (TEAC) in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs and controls (CT). Asterisks indicate significant differences between groups. *P ≤ 0.05, **P  ≤ 0.01

Full size image
Fig. 4
figure 4

Ratio between the salivary antioxidants results and salivary protein concentration. Cupric reducing antioxidant capacity (CUPRAC), ferric reducing ability of saliva (FRAS), and Trolox equivalent antioxidant capacity (TEAC) in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs and controls (CT)

Full size image

Oxidant status

Results for the salivary oxidant biomarkers are shown in Fig. 5 and 6. AOPP concentrations before microalbumin correction were significantly lower in dogs with hypothyroidism in comparison to dogs with non-thyroid diseases (P = 0.0113) and healthy dogs (P = 0.0113). When the AOPP results were corrected by salivary microalbumin no significant differences (P > 0.05) were found. No statistical differences (P > 0.05) were found for TBARS before protein correction; however, when the results were corrected by salivary protein concentration TBARS values were significantly higher in dogs with hypothyroidism in comparison to dogs with non-thyroid diseases (P = 0.0210).

Fig. 5
figure 5

Results of oxidant biomarkers in saliva. Advanced oxidation protein products (AOPP), and thiobarbituric acid reactive substances (TBARS) in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs, and controls (CT). Asterisks indicate significant differences between groups. *P ≤ 0.05

Full size image
Fig. 6
figure 6

Ratio between the salivary antioxidants results and salivary protein or microalbumin concentration. Advanced oxidation protein products (AOPP), and thiobarbituric acid reactive substances (TBARS) in dogs with hypothyroidism (HT), non-thyroid diseased (NHT) dogs, and controls (CT). Asterisks indicate significant differences between groups. *P ≤ 0.05

Full size image

Correlation study

Correlations between results obtained in serum and saliva, and serum and corrected saliva are found in Table 2. Correlations between the results of serum AOPP and corrected serum AOPP based on its albumin concentrations, and salivary AOPP and corrected salivary AOPP based on its microalbumin concentrations are found in Table 3. As shown in Table 3, serum AOPP was correlated to serum  AOPP corrected by albumin (r = 0.4175, P = 0.0006), nonetheless, no significant correlation was found between any of the biomarkers measured in both samples.

Table 2 Correlation coefficients (r) between serum and saliva, and serum and corrected saliva based on its protein concentrations in dogs
Full size table
Table 3 Correlation coefficients between serum and salivary AOPP concentrations, using obtained values and values corrected by albumin for serum (CSe) and microalbumin for saliva (CSa)
Full size table

Discussion

To the author’s knowledge, there are no reports about biomarkers of the redox status in serum and saliva of dogs with hypothyroidism. In this study, changes in various antioxidant and oxidant biomarkers were found in hypothyroid dogs that could indicate an altered redox status in this disease.

An increase in three antioxidant biomarkers (TEAC, PON-1, and GPx) was found in serum of dogs with hypothyroidism. The increases in GPx are in line with what was described in humans with Hashimoto’s thyroiditis [16, 23,24,25]. GPx is an important selenoprotein that scavenges and detoxifies H2O2, protecting thyroid cells from oxidative damage [26,27,28]. We hypothesize that the increase in GPx activity could be associated by an increased TSH stimulation, as some reports indicate that this hormone can influence GPx activity by increasing its concentrations [29].

The increase in PON-1 in hypothyroid dogs of our study differs from the decreases described in humans with hypothyroidism; in which low PON-1 values are considered a risk of atherosclerosis associated with this disease [30,31,32,33]. Dogs carry cholesterol in HDL where PON-1 is bounded protecting it from oxidation [34] instead of in LDL, as it occurs in humans. Therefore, the elevation of cholesterol that usually appears in canine hypothyroidism could imply an increase in HDL and subsequently in PON-1. This could explain the increase of PON-1 found in dogs with hypothyroidism in our study, and this increase in PON-1 could also be one of the reasons why dogs have lower risks of atherosclerosis than humans [35,36,37]. In humans, TEAC was found to be decreased in various thyroid disorders, including multinodular goitre, contrary to our results [38]. Since TEAC is an analyte that represents the effect of various antioxidants, we believe further studies should be made to evaluate if PON-1 and/or GPx influence the concentrations of TEAC. In addition, alpha-tocopherol, one of the molecules measured by TEAC, is known to be transported through lipoproteins which are increased in hypothyroidism. Although it was not evaluated in this study, increases in this antioxidant are associated with increases in lipoproteins which could explain the high TEAC levels found in this study [39].

On the other hand, in serum, three oxidant biomarkers were found to be increased in dogs with hypothyroidism, namely, TOS, POX-Act, and d-ROMs. TOS measures the total oxidant status, as it is integrated by different oxidant molecules [40]. In humans, serum TOS concentrations were found to be increased in subclinical hypothyroidism [41] and Hashimoto’s thyroiditis [42]. The increases in POX-Act and d-ROMs could be related to the increase in TOS concentrations, as both oxidants are part of the whole oxidant status of an organism [40, 43, 44].

In our study, serum AOPP concentrations without albumin correction were decreased in hypothyroid patients, however, when values were corrected, no significant changes were found, as reported in humans [1, 45]. In general, it is recommended to correct serum AOPP concentrations by albumin concentrations, as AOPP are carried by oxidized plasma proteins like albumin [46, 47], so it could be postulated that the corrected AOPP values should be considered for studies.

In saliva, FRAS and AOPP were decreased in hypothyroid dogs. However, when the salivary biomarkers were corrected by protein, no significant changes were found in these analytes. On the other hand, the salivary TBARS: protein ratio increased in dogs with hypothyroidism. Although this is a topic that should be discussed more deeply in the future, it seems that the results of saliva after correction would be more in line with what has been described in humans, since TBARS concentrations have been shown to be increased in plasma [23] and erythrocytes [48], possibly due to an increase in lipid peroxidation that is associated with the hyperlipidaemia consistently seen in hypothyroidism [49, 50]. In our study, no significant changes were observed in TBARS serum or saliva without correction in dogs with hypothyroidism. Therefore, it could be suggested that for TBARS, the correction of salivary results by protein could be more sensitive to detect the oxidant overproduction occurring in dogs with hypothyroidism, which is evidenced by the increases in TOS, POX-Act, and d-ROMs in serum. However, further studies should be performed using a larger number of animals and ideally also in dogs going through levothyroxine replacement therapy to confirm the results of our report. The divergences observed between serum and salivary TBARS are in line with the lack of correlation shown, as well as in the other serum and saliva biomarkers of redox status of our study, as divergencies in the composition of both fluids have been described in other reports in dogs [51], pigs [52] and humans [53].

This report should be considered a preliminary study, and, as previously mentioned, further trials with larger populations should be made to evaluate the changes in the oxidative status analytes used in this study throughout treatment. Also, an evaluation of the biomarkers in other sample types, such as whole blood and red blood cell lysates should be performed, since in a previous study these samples provided additional interesting information about the redox status in dogs [54]. In addition, further studies should be made to evaluate the applicability of these biomarkers in the diagnosis of this disease and treatment monitorization. These studies should assess if the presence of changes found in serum and saliva in dogs with clinical signs compatible with hypothyroidism could possibly help on the suspicion of this disease and also evaluate if the normalization of these biomarkers could be a sign of an adequate treatment.

Conclusions

Biomarkers of redox status show changes in serum and saliva in canine hypothyroidism compared with both healthy and non-thyroid-diseased dogs. Namely, there was an increase of antioxidants (TEAC, PON-1, and GPx) and oxidants (TOS, POX-Act, and d-ROMs) in serum of dogs and an increase in TBARS: protein ratio in dogs with hypothyroidism in comparison to healthy dogs. However, further studies should be made to confirm our results in larger populations of dogs and evaluate the practical potential of these analytes as biomarkers for this disease.

Methods

Study design

This case–control study involved client-owned dogs attending different Veterinary Clinics of Murcia Region (Spain) between March 2021 and May 2022.

Dogs were divided into three groups. A group of dogs with hypothyroidism (n = 23) following the subsequent criteria: (1) being adult dogs (over a year old), (2) not presenting other diseases, (3) not having received any treatment six months before diagnosis, (4) presence of symptoms related to the disease that justify the specific diagnosis tests (lethargy, tiredness, weight gain) [55] and (5) having the disease confirmed through specific diagnostic tests (determination of T4 and thyroid stimulating hormone (TSH)) [56]. Secondly, a group of non-thyroid diseased dogs (n = 21) with the same criteria mentioned previously was included, except for having negative results for specific thyroid diagnostic tests [56], and lastly, a control group of healthy adult dogs (n = 16) that were ruled out of any disease were included. In all cases, the nutritional status was reported based on the body condition score (BCS) 5-scale (1-thin; 2-underweight; 3-optimal (lean); 4-overweight; 5-obese) [57].

Samples were obtained after 12 h of fasting. Blood samples were obtained by jugular venipuncture after the saliva collection. In brief, saliva was obtained by introducing a sponge into the dog’s mouth for one to two minutes until wet and then placed into a Salivette tube (Salivette, Sarstedt, Aktiengesellschaft & CO., Nümbrecht, Germany). All tubes with blood and saliva were stored with ice until taken to the laboratory, where they were centrifuged at 3000 × g for 20 min at 4 ºC. Obtained serum and saliva were collected and transferred into 1.5 mL tubes and stored at -80ºC until analysis. All samples were obtained by the clinicians and were sent to our laboratory for further analysis. None of the dogs used in this study showed any clinical signs of periodontitis. Informed consent was taken from the dog owners.

Assays

Antioxidant status

The determination of the CUPRAC assay was based on the reduction of Cu2+ into Cu1+ by the nonenzymatic antioxidants in the sample [58]. Evaluation of CUPRAC was made following the procedure previously validated for use in serum of dogs [59]. Results are expressed in millimoles per liter (mmol/L). CUPRAC was measured in serum and saliva.

Determination of the FRAP/FRAS assay was based on the reduction of ferric-tripyridyltriazine (Fe3+-TPTZ) to the ferrous (Fe2+) form [60] by the sample. Its determination was made following previously described methods [60, 61]. Results are expressed in mmol/L. This assay was measured in serum (FRAP) and saliva (FRAS).

Measurement of TEAC was based on the assay described by Arnao et al. [62] that has been used previously in canine serum samples [63]. Its principle is based on the enzymatic generation of 2,2’-azino-bis(3-ethylbenz-thiazoline-6-sulfonic acid) (ABTS) radical and its reduction by non-enzymatic antioxidants present in the sample [62]. Results are expressed in mmol/L. TEAC was measured in serum and saliva.

The determination of total thiol is based on the reaction of thiols within the sample with 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB). The assay used was performed according to previously described methods for serum samples [64, 65]. Results are expressed in micromoles per liter (µmol/L). Thiol was measured in serum but could not be detected in saliva.

Measurement of PON-1 was based on the hydrolysis of phenyl acetate into phenol and it was determined as previously described in canine serum [66]. Results are expressed in units per milliliter (IU/ml). PON-1 was measured in serum but could not be measured in saliva.

Measurement of GPx was based on the use of commercially available assays following the manufacturer’s instructions (Randox, Crumlin, UK), as used in previous studies [67, 68]. Results are expressed in IU/ml. GPx was measured in serum but could not be measured in saliva.

Oxidant status

Determination of TOS was based on the assay described by Erel [40] that was previously used in dogs [69]. Its reaction is based on the ability of oxidants in the sample to oxidize Fe 2+-o-dianisidine complex to Fe3+ [40]. Results are expressed in µmol/L. TOS was measured in serum but could not be detected in saliva.

Evaluation of the POX-Act assay was based on the determination of total peroxides through a peroxide-peroxidase reaction using tetramethylbenzidine as the chromogenic substrate [44]. Determination of POX-Act was measured following a validated method for human sera [44]. Results are expressed in µmol/L. POX-Act was measured in serum but could not be measured in saliva.

Measurement of the d-ROMs assay was based on the reaction of the sample in an acidic medium in the presence of N,N,-diethyl-para-phenylenediamine (DEPPD), and it was made following a previously described method [43]. Results are expressed in Carratelli Units (U.CARR). d-ROMs was measured in serum but could not be measured in saliva.

Determination of AOPP was based on oxidized albumin and di-tyrosine containing cross-linked proteins, as previously described [47], and measured in canine serum [70]. Results are expressed in µmol/L. AOPP was measured in serum and saliva.

Determination of TBARS is based on the reaction of the sample to a Trichloroacetic acid, thiobarbituric acid, and N hydrochloric acid in heated conditions [71]. TBARS was measured following a previously described method [71] using a microplate reader (Powerwave XS, Biotek Instruments). Results are expressed in µmol/L. TBARS was measured in serum and saliva.

Proteins

Salivary protein concentration was measured using a commercially available colorimetric kit (protein in urine and CSF, Spinreact, Spain) as done in previous studies [72]. Results are expressed in milligrams per milliliter (mg/mL).

Microalbumin was measured in saliva using a commercially available (Microalbumin spectrophotometry kit, REF 22,324, Biosystems, Barcelona, Spain). Results are expressed in milligrams per deciliter (mg/dL).

Salivary values for all assays were corrected according to total protein concentrations found on each saliva sample as performed previously [73], meanwhile, salivary AOPP values were corrected using salivary microalbumin concentrations, as well as serum AOPP values were corrected using serum albumin concentrations, according to previous reports [46, 47].

Statistical analysis

Data were analyzed using GraphPad Prism software (GraphPad Software Inc., version 9.3 for MacOS). The Shapiro–Wilk test was first used to assess whether the results for each analyte were normally distributed. Differences in the concentrations between groups, when data were normally distributed, were assessed using a One-way ANOVA followed by Tukey’s multiple comparisons range test, and non-normally distributed data were assessed with a One-way ANOVA followed by the Kruskal–Wallis test. Correlation between saliva and serum was assessed using Pearson’s and Spearman’s correlation tests, according if the data were normally distributed or not. Statistical differences were considered for P-values < 0.05. Parametric data is shown as mean ± standard deviation (SD), meanwhile, non-parametric data is shown as median and interquartile range (IQR).

Availability of data and materials

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

T4:

Tetraiodothyronine

T3:

Triiodothyronine

ROS:

Reactive oxygen species

SOD:

Superoxide dismutase activity

TBARS:

Thiobarbituric acid reactive substances

CUPRAC:

Cupric reducing antioxidant capacity

FRAP:

Ferric reducing ability of plasma

FRAS:

Ferric reducing ability of saliva

PON-1:

Paraoxonase type-1

GPx:

Glutathione peroxidase activity

TOS:

Total oxidant status

POX-Act:

Peroxide-activity

d-ROMs:

Reactive oxygen-derived compounds

AOPP:

Advanced oxidation protein products

TSH:

Thyroid stimulating hormone;

BCS:

Body condition score

ABTS:

2,2’-Azino-bis(3-ethylbenz-thiazoline-6-sulfonic acid)

DTNB:

Dithiobis-(2-nitrobenzoic acid)

DEPPD:

N,N,-Diethyl-para-phenylenediamine

References

  1. Cheserek MJ, Wu G-R, Ntazinda A, Shi Y-H, Shen L-Y, Le G-W. Association Between Thyroid Hormones, Lipids and Oxidative Stress Markers in Subclinical Hypothyroidism / Povezanost Izme\U Tireoidnih Hormona, Lipida I Markera Oksidativnog Stresa U SubkliniĉKoj Hipotireozi. J Med Biochem. 2015;34:323–31.

    Article  Google Scholar 

  2. Jaiswal M, Tiwari A, Gupta D, Pavan Kumar M, Singh B, Maravi P, et al. Recent approaches in diagnosis and management of canine hypothyroidism: a review. ~ 90 ~ Pharma Innov J. 2018;7:90–4.

  3. Chakrabarti S, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S. Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian J Endocrinol Metab. 2016;20:674.

    Article  Google Scholar 

  4. Chainy GBN, Sahoo DK. Hormones and oxidative stress: an overview. Free Radic Res. 2020;54:1–26.

    Article  CAS  Google Scholar 

  5. Sies H. Oxidative stress: From basic research to clinical application. Am J Med. 1991;91(3 C):S31-8.

    Article  Google Scholar 

  6. Villanueva I, Alva-Sánchez C, Pacheco-Rosado J. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxid Med Cell Longev. 2013;2013:218145.

    Article  CAS  Google Scholar 

  7. Venditti P, Puca A, Di Meo S. Effects of thyroid state on H2O2 production by rat heart mitochondria: sites of production with complex I- and complex II-linked substrates. Horm Metab Res = Horm und Stoffwechselforsch = Horm Metab. 2003;35:55–61.

    Article  CAS  Google Scholar 

  8. Resch U, Helsel G, Tatzber F, Sinzinger H. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med. 2002;40:1132–4.

    Article  CAS  Google Scholar 

  9. Duntas LH. Oxidants, antioxidants in physical exercise and relation to thyroid function. Horm Metab Res. 2005;37:572–6.

    Article  CAS  Google Scholar 

  10. Silva JE. Thermogenic Mechanisms and Their Hormonal Regulation. Physiol Rev. 2006;86:435–64.

    Article  CAS  Google Scholar 

  11. Reddy S, Swapna LA, Ramesh T, Singh TR, Pradeep K. Influence of cigarette smoking on blood and salivary super oxide dismutase levels among smokers and non-smokers. J Investig Clin Dent. 2012;3:298–303.

    Article  Google Scholar 

  12. Masullo LF, Magalhães RA, Lemes RPG, de Almeida Filho TP, de Castro MF, Maia Filho PA, et al. Levothyroxine Replacement Improves Oxidative Status in Primary Hypothyroidism. Front Endocrinol (Lausanne). 2018;9 November:1–5.

  13. Dumitriu L, Bartoc R, Ursu H, Purice M, Ionescu V. Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie. 1988;26:35–8.

    CAS  Google Scholar 

  14. Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D, Güler S. The relationship between oxidative stress and autoimmunity in Hashimoto’s thyroiditis. Eur J Endocrinol. 2015;173:791–9.

    Article  CAS  Google Scholar 

  15. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf). 2009;70:469–74.

    Article  Google Scholar 

  16. Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J. Enhanced oxidative stress in Hashimoto’s thyroiditis: Inter-relationships to biomarkers of thyroid function. Clin Biochem. 2013;46:308–12.

    Article  CAS  Google Scholar 

  17. Morawska K, Maciejczyk M, Popławski Ł, Popławska-Kita A, Krętowski A, Zalewska A. Enhanced Salivary and General Oxidative Stress in Hashimoto’s Thyroiditis Women in Euthyreosis. J Clin Med. 2020;9:2102.

    Article  Google Scholar 

  18. Tóthová L, Kamodyová N, Červenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol. 2015;5 OCT.

  19. Cerón JJ. Acute phase proteins, saliva and education in laboratory science: An update and some reflections. BMC Vet Res. 2019;15:1–8.

    Article  Google Scholar 

  20. Parra MD, Tecles F, Martínez-Subiela S, Cerón JJ. C-reactive protein measurement in canine saliva. J Vet diagnostic Investig Off Publ Am Assoc Vet Lab Diagnosticians Inc. 2005;17:139–44.

    Article  Google Scholar 

  21. Giménez-Egido JM, Hernández-García R, Escribano D, Martínez-Subiela S, Torres-Luque G, Ortega-Toro E, et al. Changes in markers of oxidative stress and α-amylase in saliva of children associated with a tennis competition. Int J Environ Res Public Health. 2020;17:1–12.

    Article  Google Scholar 

  22. Cerón JJ, Contreras-Aguilar MD, Escribano D, Martínez-Miró S, López-Martínez MJ, Ortín-Bustillo A, et al. Basics for the potential use of saliva to evaluate stress, inflammation, immune system, and redox homeostasis in pigs. BMC Vet Res. 2022;18:1–17.

    Article  Google Scholar 

  23. Nanda N, Bobby Z, Hamide A. Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference Clin Exp Med. 2008;8:101–8.

    Article  CAS  Google Scholar 

  24. Reddy VS, Gouroju S, Suchitra MM, Suresh V, Sachan A, Srinivasa Rao PVLN, et al. Antioxidant defense in overt and subclinical hypothyroidism. Horm Metab Res. 2013;45:754–8.

    Article  CAS  Google Scholar 

  25. Petrulea M, Muresan A, Dunce I. Oxidative Stress and Antioxidant Status in Hypo- and Hyperthyroidism. Antioxid Enzym. 2012. https://doi.org/10.5772/51018.

    Article  Google Scholar 

  26. Kochman J, Jakubczyk K, Bargiel P, Janda-Milczarek K. The influence of oxidative stress on thyroid diseases. Antioxidants. 2021;10:1–11.

    Article  Google Scholar 

  27. Aruoma OI. Free radicals, oxidative stress, and antioxidants in human health and disease. JAOCS, J Am Oil Chem Soc. 1998;75:199–212.

    Article  CAS  Google Scholar 

  28. Nourbakhsh M, Ahmadpour F, Chahardoli B, Malekpour-Dehkordi Z, Nourbakhsh M, Hosseini-Fard SR, et al. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism. J Trace Elem Med Biol. 2016;34:10–4.

    Article  CAS  Google Scholar 

  29. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol. 2005;184:455–65.

    Article  CAS  Google Scholar 

  30. Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest. 2003;26:703–9.

    Article  CAS  Google Scholar 

  31. Shih DM, Gu L, Hama S, Xia YR, Navab M, Fogelman AM, et al. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest. 1996;97:1630–9.

    Article  CAS  Google Scholar 

  32. Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest. 1997;99:2005–19.

    Article  CAS  Google Scholar 

  33. Al-Naimi M, Hussien N, Rasheed H, Al-kuraishy H, Al-Gareeb A. Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case–control study. J Adv Pharm Technol Res. 2018;9:113.

    Article  CAS  Google Scholar 

  34. Kuleš J, Horvatić A, Guillemin N, Ferreira RF, Mischke R, Mrljak V, et al. The plasma proteome and the acute phase protein response in canine pyometra. J Proteomics. 2020;223: 103817.

    Article  Google Scholar 

  35. Vitale CL, Olby NJ. Neurologic dysfunction in hypothyroid, hyperlipidemic Labrador Retrievers. J Vet Intern Med. 2007;21:1316–22.

    Article  Google Scholar 

  36. Downs LG, Bolton CH, Crispin SM, Wills JM. Plasma lipoprotein lipids in five different breeds of dogs. Res Vet Sci. 1993;54:63–7.

    Article  CAS  Google Scholar 

  37. Rochu D, Chabrière E, Masson P. Paraoxonase-1 and its interactions with HDL: Molecular structures of PON1 and HDL. 2010.

  38. Ramli NSF, Mat Junit S, Leong NK, Razali N, Jayapalan JJ, Abdul AA. Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders. PeerJ. 2017;5:e3365.

    Article  Google Scholar 

  39. Davies T, Kelleher J, Losowsky MS. Interrelation of serum lipoprotein and tocopherol levels. Clin Chim Acta. 1969;24:431–6.

    Article  CAS  Google Scholar 

  40. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11.

    Article  CAS  Google Scholar 

  41. Roshni, Prabhu KA, Rao YD, Sowndarya K, Nandini M. Assessment of oxidative stress index in sub-clinical hypothyroidism. Biomed Pharmacol J. 2021;14:739–48. https://doi.org/10.13005/bpj/2177.

  42. Ates I, Arikan MF, Altay M, Yilmaz FM, Yilmaz N, Berker D, et al. The effect of oxidative stress on the progression of Hashimoto’s thyroiditis. Arch Physiol Biochem. 2018;124:351–6.

    Article  CAS  Google Scholar 

  43. Alberti A, Bolognini L, Macciantelli D, Caratelli M. The radical cation of N, N-diethyl-para-phenylendiamine: A possible indicator of oxidative stress in biological samples. Res Chem Intermed. 2000;26:253–67.

    Article  CAS  Google Scholar 

  44. Tatzber F, Griebenow S, Wonisch W, Winkler R. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem. 2003;316:147–53.

    Article  CAS  Google Scholar 

  45. Chen Y, Zhou Z, Li XX, Wang T. Research on the protective effects of antioxidants on metabolic syndrome induced by thyroid dysfunction. Eur Rev Med Pharmacol Sci. 2017;21:2489–98.

    CAS  Google Scholar 

  46. Šebeková K, Klenovicsová K, Ferenczová J, Hedvig J, Podracká L, Heidland A. Advanced Oxidation Protein Products and Advanced Glycation End Products in Children and Adolescents With Chronic Renal Insufficiency. J Ren Nutr. 2012;22:143–8.

    Article  Google Scholar 

  47. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.

    Article  CAS  Google Scholar 

  48. Santi A, Duarte MMMF, de Menezes CC, Loro VL. Association of Lipids with Oxidative Stress Biomarkers in Subclinical Hypothyroidism. Int J Endocrinol. 2014;2012(2012):1–7.

    Google Scholar 

  49. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76–84.

    Article  CAS  Google Scholar 

  50. Bouderbala S, Lamri-Senhadji M, Prost J, Lacaille-Dubois MA, Bouchenak M. Changes in antioxidant defense status in hypercholesterolemic rats treated with Ajuga iva. Phytomedicine. 2008;15:453–61.

    Article  CAS  Google Scholar 

  51. Franco-Martínez L, Gelemanović A, Horvatić A, Contreras-Aguilar MD, Mrljak V, Joaquín Cerón J, et al. The serum and saliva proteome of dogs with diabetes mellitus. Animals. 2020;10:1–16.

    Article  Google Scholar 

  52. Rivera-Gomis J, Rubio CP, Conesa CM, Salaverri JO, Cerón JJ, Tortosa DE, et al. Effects of dietary supplementation of garlic and oregano essential oil on biomarkers of oxidative status, stress and inflammation in postweaning piglets. Animals. 2020;10:1–17.

    Article  Google Scholar 

  53. Punj A, Shenoy S, Kumari NS, Pampani P. Estimation of Antioxidant Levels in Saliva and Serum of Chronic Periodontitis Patients with and without Ischemic Heart Disease. Int J Dent. 2017;2017:1–9.

    Article  Google Scholar 

  54. González-Arostegui LG, Muñoz-Prieto A, Tvarijonaviciute A, Cerón JJ, Rubio CP. Measurement of Redox Biomarkers in the Whole Blood and Red Blood Cell Lysates of Dogs. Antioxidants. 2022;11:424.

    Article  Google Scholar 

  55. Mooney CT. Canine hypothyroidism: a review of aetiology and diagnosis. N Z Vet J. 2011;59:105–14.

    Article  CAS  Google Scholar 

  56. Kemppainen RJ, Clark TP. Etiopathogenesis of canine hypothyroidism. Vet Clin North Am Small Anim Pract. 1994;24:467–76.

    Article  CAS  Google Scholar 

  57. Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc. 1999;214:1336–41.

    CAS  Google Scholar 

  58. Campos C, Guzmán R, López-Fernández E, Casado Á. Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: The CUPRAC-BCS assay. Anal Biochem. 2009;392:37–44.

    Article  CAS  Google Scholar 

  59. Rubio C, Tvarijonaviciute A, Martinez-Subiela S, Hernández-Ruiz J, Cerón JJ. Validation of an automated assay for the measurement of cupric reducing antioxidant capacity in serum of dogs. BMC Vet Res. 2016;12:137.

    Article  Google Scholar 

  60. Benzie IFF, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a measure of “Antioxidant Power”: the FRAP Assay. Anal Biochem. 1996;239:70–6.

    Article  CAS  Google Scholar 

  61. Camila Peres Rubio, Silvia Martinez-Subiela, Josefa Hernández-Ruiz A, Tvarijonaviciute JJC. Analytical validation of an automated assay for ferric-reducing ability of plasma in dog serum. J Vet Diagnostic Investig. 2017;1:1–5.

  62. Arnao MB, Cano A, Hernández-Ruiz J, García-Cánovas F, Acosta M. Inhibition by L-Ascorbic Acid and Other Antioxidants of the 2,2′-Azino-bis(3-ethylbenzthiazoline-6-sulfonic Acid) Oxidation Catalyzed by Peroxidase: A New Approach for Determining Total Antioxidant Status of Foods. Anal Biochem. 1996;236:255–61.

    Article  CAS  Google Scholar 

  63. Rubio CP, Hernández-Ruiz J, Martinez-Subiela S, Tvarijonaviciute A, Arnao MB, Ceron JJ. Validation of three automated assays for total antioxidant capacity determination in canine serum samples. J Vet Diagnostic Investig. 2016;28:693–8.

    Article  CAS  Google Scholar 

  64. Da Costa CM, Dos Santos RCC, Lima ES. A simple automated procedure for thiol measurement in human serum samples. J Bras Patol e Med Lab. 2006;42:345–50.

    Google Scholar 

  65. Jocelyn PC. Spectrophotometric Assay of Thiols. Methods Enzymol. 1987;143 C:44–67.

    Article  Google Scholar 

  66. Tvarijonaviciute A, Tecles F, Caldin M, Tasca S, Cerón J. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am J Vet Res. 2012;73:34–41.

    Article  CAS  Google Scholar 

  67. Kapun AP, Salobir J, Levart A, Kotnik T, Svete AN. Oxidative stress markers in canine atopic dermatitis. Res Vet Sci. 2012;92:469–70.

    Article  CAS  Google Scholar 

  68. Verk B, Nemec Svete A, Salobir J, Rezar V, Domanjko PA. Markers of oxidative stress in dogs with heart failure. J Vet Diagnostic Investig. 2017;29:636–44.

    Article  CAS  Google Scholar 

  69. Rubio CP, Martinez-Subiela S, Tvarijonaviciute A, Hernández-Ruiz J, Pardo-Marin L, Segarra S, et al. Changes in serum biomarkers of oxidative stress after treatment for canine leishmaniosis in sick dogs. Comp Immunol Microbiol Infect Dis. 2016;49:51–7.

    Article  Google Scholar 

  70. Rubio CP, Tvarijonaviciute A, Caldin M, Hernández-Ruiz J, Cerón JJ, Martínez-Subiela S, et al. Stability of biomarkers of oxidative stress in canine serum. Res Vet Sci. 2018;121 September:85–93.

  71. Buege JA, Aust SD. Biomembranes - Part C: Biological Oxidations. Methods Enzymol. 1978;52:302–10.

    Article  CAS  Google Scholar 

  72. González-Hernández JM, Franco L, Colomer-Poveda D, Martinez-Subiela S, Cugat R, Cerón JJ, et al. Influence of Sampling Conditions, Salivary Flow, and Total Protein Content in Uric Acid Measurements in Saliva. Antioxidants. 2019;8:389.

    Article  Google Scholar 

  73. Gyurászová M, Kovalčíková A, Janšáková K, Šebeková K, Celec P, Tóthová Ľ. Markers of oxidative stress and antioxidant status in the plasma, urine and saliva of healthy mice. Physiol Res. 2018;67:921–34.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by the Seneca Foundation-Agency of Science and Technology of the Region of Murcia through the Subprogram to the Scientific Leadership and the Transition to the Independent Investigation (20649/JLI/18). LG-A was funded by 21453/FPI/20, Fundación Séneca, Región de Murcia, Spain. AM-P was funded by the University of Murcia through a post-doctoral grant (Margarita Salas) within the mark of “Ayudas en el marco del Programa de Recualificación del Sistema Universitario Español” through the European Union Next Generation Funds. CP-R has a post-doctoral fellowship “Juan de la Cierva Formación” supported by the “Ministerio de Economía y Competitividad” (FJC2019-042475-I).

Author information

Authors and Affiliations

  1. Interdisciplinary Laboratory of Clinical Analysis (Interlab-UMU), Veterinary School, Campus of Excellence Mare Nostrum, University of Murcia, 30100, Murcia, Espinardo, Spain

    Luis G. González Arostegui, Luis Pardo Marín, Gregorio García López, Asta Tvarijonaviciute & Jose Joaquín Cerón Madrigal

  2. Clinic for Internal Diseases, Faculty of Veterinary Medicine, University of Zagreb, Heinzelova 55, 1000, Zagreb, Croatia

    Alberto Muñoz Prieto

  3. Department of Animal and Food Science, School of Veterinary Science, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

    Camila Peres Rubio

Authors
  1. Luis G. González Arostegui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Muñoz Prieto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Pardo Marín
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregorio García López
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Asta Tvarijonaviciute
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jose Joaquín Cerón Madrigal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Camila Peres Rubio
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L-GA, JJC, and CPR conceived and designed the study. L-GA, A-MP, and L-PM collected the data. L-GA, G-GL, and CPR were involved in the chemical analysis. L-GA, A-MP, AT, JJC, and CPR were involved in the data interpretation. L-GA drafted the manuscript and A-MP, AT, JJC and CPR critically read and edited the manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Camila Peres Rubio.

Ethics declarations

Ethics approval and consent to participate

This project has been approved by the Murcia University Ethics Committee with the number CEEA 288/2017. Informed consent was taken from all dog owners. All experiments were performed in accordance with relevant guidelines in regulations, as well as with ARRIVE guidelines for animal experimentation.

Consent for publication

Not applicable.

Competing interests

None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. Description of the methods and the reagents used on the assays performed in the study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arostegui, L.G.G., Prieto, A.M., Marín, L.P. et al. Changes in biomarkers of redox status in serum and saliva of dogs with hypothyroidism. BMC Vet Res 19, 33 (2023). https://doi.org/10.1186/s12917-023-03586-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-023-03586-4

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us